1. Home
  2. BOLD vs NDLS Comparison

BOLD vs NDLS Comparison

Compare BOLD & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • NDLS
  • Stock Information
  • Founded
  • BOLD 2018
  • NDLS 1995
  • Country
  • BOLD United States
  • NDLS United States
  • Employees
  • BOLD N/A
  • NDLS N/A
  • Industry
  • BOLD
  • NDLS Restaurants
  • Sector
  • BOLD
  • NDLS Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • BOLD 30.3M
  • NDLS 32.9M
  • IPO Year
  • BOLD 2024
  • NDLS 2013
  • Fundamental
  • Price
  • BOLD $1.16
  • NDLS $0.87
  • Analyst Decision
  • BOLD Buy
  • NDLS Strong Buy
  • Analyst Count
  • BOLD 3
  • NDLS 2
  • Target Price
  • BOLD $4.00
  • NDLS $3.00
  • AVG Volume (30 Days)
  • BOLD 351.6K
  • NDLS 216.2K
  • Earning Date
  • BOLD 08-11-2025
  • NDLS 08-06-2025
  • Dividend Yield
  • BOLD N/A
  • NDLS N/A
  • EPS Growth
  • BOLD N/A
  • NDLS N/A
  • EPS
  • BOLD N/A
  • NDLS N/A
  • Revenue
  • BOLD N/A
  • NDLS $495,670,000.00
  • Revenue This Year
  • BOLD N/A
  • NDLS $5.37
  • Revenue Next Year
  • BOLD N/A
  • NDLS $0.68
  • P/E Ratio
  • BOLD N/A
  • NDLS N/A
  • Revenue Growth
  • BOLD N/A
  • NDLS N/A
  • 52 Week Low
  • BOLD $1.00
  • NDLS $0.55
  • 52 Week High
  • BOLD $4.72
  • NDLS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • NDLS 51.14
  • Support Level
  • BOLD N/A
  • NDLS $0.66
  • Resistance Level
  • BOLD N/A
  • NDLS $0.85
  • Average True Range (ATR)
  • BOLD 0.00
  • NDLS 0.07
  • MACD
  • BOLD 0.00
  • NDLS 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • NDLS 80.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: